COVID-19 Vaccine Updates

Access and complete the vaccine portal and complete your profile in just three steps:

  1. Go to https://www.utrgv.edu/vaccineportal
  2. Sign in using your UTRGV credentials
  3. Complete your profile and submit

Once eligible, and supply is available, your portal registration code will serve as your key toward selecting an appointment through our online scheduling platform. Be sure to update your profile should your interest or status change. You can do so by following these steps. Completing your profile not only helps us measure vaccine demand — it also helps us track our progress toward "Herd Immunity" within our campus community, so we can return to normal face-to-face operations as soon as possible.

Portal Technical Guide and Tips

Desktop

The best portal experience is via a desktop computer. Please make sure you are using the latest version of Chrome and have enabled third-party cookies.

Mobile

iPhone users may need to adjust the device's privacy settings and enable third-party cookies on the browser.

If you're experiencing difficulties accessing the portal via a mobile device, try downloading the Power Apps application from your preferred app store. Once you do, log in with your UTRGV email/password and select UTRGV Vaccine Portal. Using Power Apps will also allow you to receive direct notifications and updates regarding your profile information.

Thank you for your patience and trust in UT Health RGV as we navigate the vaccination process.

For any questions or concerns, please feel free to contact us at coronavirus@utrgv.edu


*Note: Regardless of your vaccination status (I.e., received the first dose, fully vaccinated, or unvaccinated), every UTRGV employee must continue following all health and safety protocols put forth by the university. You can reference the face-covering protocol and other guidelines here.


COVID-19 Vaccine Guidelines & Resources

Details on Phase 1B Medical Conditions

  • Cancer

    List of common cancers (CDC)

  • Diabetes, such as but not limited to:
    • Type 2 diabetes mellitus
    • Type 1 diabetes mellitus
  • Chronic kidney disease, such as but not limited to:
    • glomerulonephritis
    • polycystic kidney disease
  • Immunocompromised diseases and states, such as but not limited to:
    • HIV
    • cancer
    • weakened immune system from blood, bone marrow, or organ transplant
    • use of corticosteroids
    • use of other immune weakening medicines
    • use of stem cells for cancer treatment
    • genetic immune deficiencies
  • Chronic lung diseases, such as but not limited to:
    • asthma (moderate-to-severe)
    • cystic fibrosis
    • COPD (chronic obstructive pulmonary disease)
    • pulmonary fibrosis (having damaged or scarred lung tissues)
    • sleep apnea
  • Sickle cell disease
  • Chronic heart disease, such as but not limited to:
    • heart failure
    • coronary artery disease
    • cardiomyopathies
  • High blood pressure (hypertension)
  • Chronic neurological diseases, such as but not limited to:
  • Obesity
  • Pregnancy